Press release
September 3, 2026
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
Harmony Biosciences Holdings, Inc. (HRMY)
PLYMOUTH MEETING, Pa., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore data from the company’s investigation of EPX-100 (clemizole hydrochloride) at the 16 th European Epilepsy Congress being held from September 5-9,